Highlights
Medical Products Business Division
Our Medical device business
integrate with Kawasumi
Laboratories, Inc. as of
1st October, 2021 and
we start the brand new
company as
SB-KAWASUMI
LABORATORIES, INC.
Topics More
- 2025/08/28 Newsletter [S-BIO Insight] Redifferentiation of Dedifferentiated Hepatocytes (dediHeps) Aggregated with PrimeSurface™ and its potential for Regenerative Medicine Applications™
- 2025/07/24 Newsletter [S-BIO Insight] Potential for a New Cervical Cancer Treatment Using Mesothelin-Targeted CAR-NK Cells cultured with PrimeSurface™
- 2025/07/22 Products Acquisition of AGC Group’s Polycarbonate Business
- 2025/06/18 Newsletter [S-BIO Insight] New study on personalized Vascularized Models of Breast Cancer Desmoplasia using PrimeSurface™ and MPS
- 2025/06/16 Products Commercialization of the World’s First Biomass-Derived Solid Novolac-Type Lignin-Modified Phenolic Resin
Inquiry
FAQ